PET-CT as standard for FDG-avid lymphomas
E1312972
UNEXPLORED
PET-CT as standard for FDG-avid lymphomas refers to the use of fluorodeoxyglucose positron emission tomography combined with computed tomography as the primary imaging modality for staging and response assessment in lymphomas that avidly take up FDG.
All labels observed (1)
| Label | Occurrences |
|---|---|
| PET-CT as standard for FDG-avid lymphomas canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T18213098 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: PET-CT as standard for FDG-avid lymphomas Context triple: [Lugano classification, recommends, PET-CT as standard for FDG-avid lymphomas]
-
A.
non-Hodgkin lymphoma
Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
-
B.
Hodgkin lymphoma
Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
-
C.
ABVD regimen
The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
-
D.
Leukemia and Lymphoma Research
Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
-
E.
Hodgkin
Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: PET-CT as standard for FDG-avid lymphomas Target entity description: PET-CT as standard for FDG-avid lymphomas refers to the use of fluorodeoxyglucose positron emission tomography combined with computed tomography as the primary imaging modality for staging and response assessment in lymphomas that avidly take up FDG.
-
A.
non-Hodgkin lymphoma
Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
-
B.
Hodgkin lymphoma
Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
-
C.
ABVD regimen
The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
-
D.
Leukemia and Lymphoma Research
Leukemia and Lymphoma Research is a UK-based medical research charity dedicated to improving the diagnosis, treatment, and prevention of blood cancers such as leukemia and lymphoma.
-
E.
Hodgkin
Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.